Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

8:40 AM ET 8-K
Financial Results Aprea Therapeutics, Inc. APRE

Aprea Therapeutics Financial Results

Aprea Therapeutics reported third quarter 2026 financial results and provided a clinical update on its oral WEE1 inhibitor, APR-1051. The company expanded its Phase 1 clinical trial network to nine sites and expects to select a dose for the optimization phase of the study in the first half of 2027.

“We continue to make meaningful progress in advancing APR-1051 towards our goal of developing a differentiated, potentially best-in-class WEE1 inhibitor for patients with biomarker defined cancers.”

Oren Gilad, Ph.D., President and Chief Executive Officer

“With $37.8 million in cash and cash equivalents as of September 30, 2026, and an expected cash runway into the first quarter of 2028, we believe we are well positioned to execute our clinical development strategy, achieve meaningful milestones, and create long-term value for patients and shareholders.”

Oren Gilad, Ph.D., President and Chief Executive Officer
8:38 AM ET 8-K
Financial Results Clene Inc. CLNN

Clene Financial Results

Clene Inc. reported third quarter 2026 financial results, highlighting the submission of a New Drug Application (NDA) to the FDA for CNM-Au8 in ALS. The company ended the quarter with $9.9 million in cash, bolstered by a $4.0 million registered direct offering completed in September, providing a runway through mid-first quarter 2027.

“Clene’s submission of the NDA for CNM-Au8 is a pivotal achievement for the company and, more importantly, a meaningful step toward bringing new treatment options to people living with ALS. People living with ALS urgently need additional treatment options, and we appreciate the FDA’s constructive engagement throughout this process. We look forward to working closely with the Agency during its pending review. We believe CNM-Au8 has the capacity to restore and protect neuronal health and function and improve survival.”

Rob Etherington, President and CEO of Clene
8:37 AM ET 6-K
Financial Results Cenovus Energy Inc. CVE

Cenovus Energy Q3 2026 Results: Net Income $3.36B, Up 161.3% YoY

Cenovus Energy achieved record quarterly production exceeding one million BOE/d in Q3 2026, driven by record performance at Christina Lake, Foster Creek, and Sunrise. The company reported net earnings of $3.4 billion and announced a definitive agreement to acquire Athabasca Oil Corporation for $5.7 billion, expected to close in December 2026.

Key figure
Net income $3.36B · +161.3% YoY
8:37 AM ET 10-Q
Financial Results Vishay Precision Group, Inc. VPG ▶ Call

Vishay Precision Group Q3 2026 Results: Net Income $559K, Down 92.9% YoY

Vishay Precision Group reported net revenues for the third quarter of 2026 that were reduced by $2.3 million due to tariff refunds passed through to customers. The company maintains a dual-class common stock structure with approximately 12.3 million shares of Common Stock and 1.0 million shares of Class B convertible stock outstanding.

Key figure
Net income $559K · -92.9% YoY
8:37 AM ET 8-K
Financial Results Nnn REIT, Inc. NNN

Nnn REIT Financial Results

NNN REIT reported third quarter 2026 financial results with net earnings of $0.57 per diluted share and Core FFO growth of 5.9% year-over-year. The company maintained its full-year 2026 Core FFO guidance of $3.50 - $3.54 per share while reporting a high portfolio occupancy rate of 99.2%.

Term
Q3 2026

“We are pleased to report strong third quarter results, highlighted by continued healthy portfolio trends, solid investment activity, and well-timed equity capital markets execution. With $1.4 billion of available liquidity and a balance sheet built for all market cycles, we are well positioned to execute on our investment pipeline and capitalize on the opportunities that today’s market volatility may create.”

Steve Horn, Chief Executive Officer
8:36 AM ET 8-K
Financial Results Twin Disc Inc TWIN

Twin Disc Financial Results

Twin Disc reported first quarter fiscal 2027 sales of $88.7 million, a 10.9% increase year-over-year, driven by strength in the Veth product line and defense sector demand. The company achieved net income of $3.4 million and maintained a robust six-month backlog of $190.6 million.

Term
Q1 2027

“Our fiscal 2027 first quarter results built on the strong momentum we established in fiscal 2026. Demand remains healthy across our end markets, supporting record six-month backlog of $191 million in the quarter, a 7% increase from fiscal year end.”

John H. Batten, President and CEO

“We continue to prioritize investing in our growth, including the expansion of our European footprint, the continued build-out of our manufacturing capabilities in Racine, and evaluating M&A opportunities.”

John H. Batten, President and CEO
8:34 AM ET 8-K
Financial Results Marinemax Inc HZO

Marinemax Financial Results

MarineMax reported fiscal fourth quarter 2026 revenue of $520.1 million and a net loss of $13.0 million, impacted by a challenging retail environment and costs related to its pending acquisition by Safe Harbor Marinas. Despite lower boat sales, the company achieved a 270 basis point gross margin expansion to 37.4% driven by growth in higher-margin marina and service businesses.

“Fiscal 2026 demonstrated the strength of MarineMax's diversified business model and the benefits of our strategic investments to broaden our marine offerings and expand our presence in durable, higher-margin businesses.”

Brett McGill, the Company’s Chief Executive Officer and President

“Our previously announced agreement to be acquired by Safe Harbor represents an important milestone for MarineMax and reflects the value we have created by building a broader and more diversified marine business.”

Brett McGill, the Company’s Chief Executive Officer and President
8:29 AM ET 8-K
Financial Results Ocugen, Inc. OCGN

Ocugen Financial Results

Ocugen reported Q3 2026 financial results, highlighting a cash position of $84.6 million with an expected runway into 2028. The company advanced its gene therapy pipeline, including the initiation of the Phase 3 ArMaDa3 trial for OCU410 and receiving provisional approval for OCU400 in The Bahamas.

Term
Q3 2026

“With three Phase 3 modifier gene therapy programs underway, Ocugen is executing against a clear strategy of advancing our pipeline and leveraging strategic partnerships to expand global reach and potentially bring our therapies to patients worldwide.”

Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen

“As we demonstrated in the third quarter, we remain focused on executing key clinical and regulatory milestones, expanding our commercial opportunities, and maintaining a disciplined approach as we advance toward the anticipated OCU400 Phase 3 topline data early next year.”

Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen
8:23 AM ET 8-K
Financial Results Global Indemnity Group, LLC GBLI

Global Indemnity Group Financial Results

Global Indemnity Group reported Q3 2026 net income of $8.9 million ($0.61 per share) and nine-month net income of $24.2 million ($1.65 per share). New CEO Jessica E. Buss highlighted that while the third quarter was softer due to maintaining underwriting standards in a softening property market, nine-month results ran well ahead of the prior year.

“I joined GBLI as CEO this week. I studied this company closely before accepting the role, and I came in knowing exactly where we stand and what we can become. Our results for the first nine months ran well ahead of last year. The third quarter came in softer, as we held to our underwriting standards while competitors cut property rates, and we owe our shareholders a plain account of that. We also owe them a plan.”

Jessica E. Buss, CEO of Global Indemnity

“Going forward, we will hold ourselves to one measure: sustained growth in premiums, earnings and book value per share at rates far beyond anything GBLI achieved since its founding.”

Jessica E. Buss, CEO of Global Indemnity
8:16 AM ET 10-Q
Financial Results Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings Q3 2026 Results: Net Income $48.2M, Down 5.2% YoY

Harmony Biosciences reported net product revenue of $268.9 million for the third quarter of 2026, a 12.3% increase year-over-year. Net income for the nine months ended September 30, 2026, rose to $156.1 million compared to $136.2 million in the prior year, despite higher operating expenses driven by research and development.

Key figure
Net income $48.2M · -5.2% YoY
8:11 AM ET 10-Q
Financial Results Safehold Inc. SAFE

Safehold Q3 2026 Results: Net Income $28.8M, Down 1.6% YoY

Safehold Inc. reported net income of $31.3 million for the quarter ended September 30, 2026, driven by $118.7 million in total revenues, including new hotel revenue streams. Total assets grew to $7.70 billion from $7.25 billion at year-end 2025, while the company maintained its quarterly dividend at $0.177 per share.

Key figure
Net income $28.8M · -1.6% YoY
8:11 AM ET 10-Q
Financial Results SmartRent, Inc. SMRT

SmartRent Q3 2026 Results: Net Loss of $3.91M, Loss Narrows

SmartRent, Inc. reported total assets of $289.1 million as of September 30, 2026, a decrease from $320.9 million at year-end 2025, primarily driven by lower cash and accounts receivable balances. Total liabilities also decreased from $88.8 million to $68.7 million during the same period. The company continues to focus on its 'Vision 2028' strategic plan while managing macroeconomic headwinds and leadership changes.

Key figure
Net loss $3.91M
8:08 AM ET 8-K
Financial Results UroGen Pharma Ltd. URGN

UroGen Pharma Financial Results

UroGen Pharma reported third-quarter 2026 financial results, highlighted by $68.0 million in ZUSDURI revenue, representing 35% sequential growth. The company also announced that the FDA has accepted its NDA for UGN-103 with a PDUFA goal date of June 14, 2027, and reported a cash position of $215.4 million.

“We delivered another strong quarter of execution, with ZUSDURI continuing to scale as growing repeat utilization, expanding community adoption, and broader physician engagement reinforce our confidence in the long-term commercial opportunity.”

Liz Barrett, President and Chief Executive Officer of UroGen

“The U.S. Food and Drug Administration’s (FDA’s) acceptance of the UGN-103 New Drug Application (NDA) in low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC), together with our newly issued patent providing coverage into July 2044, further reinforce the long-term revenue potential of our bladder cancer portfolio.”

Liz Barrett, President and Chief Executive Officer of UroGen
8:08 AM ET 8-K
Financial Results Southwest Gas Holdings, Inc. SWX

Southwest Gas Holdings Financial Results

Southwest Gas Holdings reported Q3 2026 financial results, highlighted by a return to profitability in continuing operations with net income of $12.8 million compared to a loss in the prior year. The company reaffirmed its full-year 2026 guidance and noted the completion of rate cases in Nevada and California that will increase annual revenue by approximately $80 million.

“Our strong results give us confidence that we are on track to achieve our full-year guidance. We achieved several important regulatory milestones, completing our Nevada and California rate cases, which resulted in approximately $80 million of combined annual revenue increases, reinforcing regulatory support for infrastructure investments and enhancing earnings visibility.”

Justin Brown, President and CEO of Southwest Gas Holdings
8:08 AM ET 10-Q
Financial Results Nuvectis Pharma, Inc. NVCT

Nuvectis Pharma Q3 2026 Results: Net Loss of $30.1M, Loss Widens

Nuvectis Pharma reported a significant increase in cash and cash equivalents to $140.7 million as of September 30, 2026, following a substantial equity issuance. However, the company continues to incur losses, with research and development expenses rising to $36.2 million for the first nine months of 2026 compared to $13.1 million in the prior year period.

Key figure
Net loss $30.1M
8:05 AM ET 8-K
Financial Results SmartRent, Inc. SMRT

SmartRent Financial Results

SmartRent reported Q3 2026 financial results featuring 15% total revenue growth and its fourth consecutive quarter of positive Adjusted EBITDA. The company achieved significant margin expansion, with gross margins reaching 41%, and reported that total units deployed reached nearly 942,000 as it executes its Vision 2028 Strategic Plan.

Term
Q3 2026

“SmartRent has now delivered four successive quarters of accelerating growth and margin trends as we successfully execute against our Vision 2028 Strategic Plan. The positive momentum extends across all facets of the business including our sales muscle, critical technology advancements and operations effectiveness.”

Frank Martell, President and Chief Executive Officer of SmartRent

“Total Revenue increased 15% year-over-year, with Core Revenue up 24%. As our footprint continues to scale, we are seeing expanding adoption of our Access Control and Self-Guided Tour solutions, alongside strong demand for equipment upgrades and refreshes.”

Daryl Stemm, Chief Financial Officer of SmartRent
8:04 AM ET 8-K
Financial Results Avnet Inc AVT

Avnet Financial Results

Avnet reported record first quarter fiscal 2027 sales of $10.7 billion, an 82% increase year-over-year, driven by strong demand in industrial, aerospace, and AI data center applications. The company achieved record adjusted diluted EPS of $3.63 and expanded its adjusted operating income margin by 210 basis points to 4.7%.

Term
Q1 2027

“We began fiscal 2027 by delivering another record quarter, reflecting stronger demand and solid execution across all of our businesses. The fundamental backdrop for our industry remains positive, with continued growth across our core verticals such as industrial, aerospace and defense, transportation and AI and data center applications.”

Phil Gallagher, Avnet Chief Executive Officer
8:04 AM ET 8-K
Financial Results W.W. Grainger, Inc. GWW

W.W. Grainger Financial Results

W.W. Grainger reported third quarter 2026 sales of $5.2 billion, an 11.3% increase year-over-year, driven by strong performance in both High-Touch Solutions and Endless Assortment segments. The company achieved adjusted diluted EPS of $12.54 and increased its full-year 2026 earnings outlook due to consistent execution and improving demand.

Term
Q3 2026

“The third quarter performance reflects our consistent execution and an improving demand environment. As customers continue to turn to us for the products and solutions they need, both our High-Touch Solutions and Endless Assortment segments delivered impressive growth. Following another quarter of strong performance, we are increasing our 2026 guidance and remain on track for an exceptional year.”

D.G. Macpherson, Chairman and CEO
8:03 AM ET 10-Q
Financial Results Trinity Capital Inc. TRIN

Trinity Capital Q3 2026 Results: Net Income $46.9M, Up 69.7% YoY

Trinity Capital Inc. reported a net increase in net assets resulting from operations of $121.2 million for the nine months ended September 30, 2026, compared to $96.1 million in the prior year period. Total investment income grew significantly to $275.7 million for the nine months, driven by an expanded investment portfolio which reached a fair value of $2.86 billion.

Key figure
Net income $46.9M · +69.7% YoY
8:03 AM ET 10-Q
Financial Results Atlanta Braves Holdings, Inc. BATRA

Atlanta Braves Holdings Q3 2026 Results: Net Income $9.8M, Down 67.3% YoY

For the nine months ended September 30, 2026, Atlanta Braves Holdings reported total revenue of $701.8 million, a 4.6% increase over the prior year, though it swung to an operating loss of $51.1 million compared to a profit in 2025. The net loss attributable to stockholders was $42.9 million, driven primarily by a significant increase in baseball operating costs and selling, general, and administrative expenses.

Key figure
Net income $9.8M · -67.3% YoY
8:01 AM ET 8-K
Financial Results Reservoir Media, Inc. RSVR

Reservoir Media Financial Results

Reservoir Media reported second quarter fiscal 2027 revenue of $49.9 million, a 10% increase year-over-year driven by strong performance in Recorded Music and Music Publishing. Net income rose to $4.6 million, or $0.07 per share, and the company raised its full-year outlook for revenue and Adjusted EBITDA.

Term
Q2 2027

“Our second quarter results marked the end of a strong first half of fiscal 2027, with growth across both our Publishing and Recorded Music segments reflecting the continued successful execution of our long-term strategy.”

Golnar Khosrowshahi, Founder and Chief Executive Officer

“We continue to thoughtfully expand and diversify our portfolio, while deepening our established reputation as a trusted steward for exceptional music talents and catalogs. We remain confident in our ability to build on this momentum for the remainder of fiscal year 2027.”

Golnar Khosrowshahi, Founder and Chief Executive Officer
8:01 AM ET 10-Q
Financial Results Burford Capital Ltd BUR

Burford Capital Q3 2026 Results: Turns Profitable, Net Income $23.4M

Burford Capital Ltd's Form 10-Q for the period ended September 30, 2026, details the company's performance in the legal finance market, emphasizing realized gains from portfolio resolutions and the valuation of capital provision assets. The report provides updates on liquidity management and the scaling of its investment portfolio amidst evolving litigation trends.

Key figure
Net income $23.4M
8:01 AM ET 8-K
Financial Results Trinity Capital Inc. TRIN

Trinity Capital Financial Results

Trinity Capital reported record third-quarter 2026 financial results, with net investment income (NII) growing 34.9% year-over-year to $49.9 million. The company funded $614.1 million in gross investments during the quarter, driving total platform assets under management to $3.4 billion. Net Asset Value (NAV) per share increased to $13.61, supported by a 15.5% return on average equity.

Term
Q3 2026

“The third quarter was another step in building a platform designed to perform across market environments. We funded $614 million, grew platform AUM to $3.4 billion, and continued to expand our managed funds offering, enhancing returns for TRIN beyond the income generated by our BDC portfolio. We like the foundation we’ve built, and we’re excited about what’s next for TRIN and our shareholders.”

Kyle Brown, Trinity Capital CEO
8:01 AM ET 10-Q
Financial Results Neuronetics, Inc. STIM ▶ Call

Neuronetics Q3 2026 Results: Net Loss of $1.69M, Loss Narrows

Neuronetics, Inc. reported total revenues of $41.96 million for the quarter ended September 30, 2026, a 12.5% increase over the prior year, driven primarily by growth in the Greenbrook segment. The company achieved a quarterly income from operations of $0.54 million compared to a loss of $7.32 million in the prior year, though it maintained a net loss of $1.56 million for the period.

Key figure
Net loss $1.69M
8:01 AM ET 8-K
Financial Results American Financial Group Inc AFG

American Financial Group Financial Results

American Financial Group reported record third quarter core net operating earnings of $3.97 per share, driven by higher net investment income and strong P&C operating performance. Alongside the results, the Board of Directors declared a special one-time cash dividend of $3.50 per share payable on November 25, 2026. The company also updated its full-year 2026 core net operating earnings guidance to a range of $12.30 to $12.80 per share.

Term
Q3 2026
8:01 AM ET 8-K
Financial Results Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings Financial Results

Harmony Biosciences reported Q3 2026 financial results with WAKIX net revenue of $269 million, driven by 400 net patient additions. The company reaffirmed its full-year 2026 revenue guidance of $1.0 billion to $1.04 billion and announced that Peter Anastasiou will succeed Jeffrey Dayno as CEO effective January 1, 2027.

“As I prepare to transition the President and CEO role to Peter on January 1, I believe Harmony is operating from a position of strength, with a durable and growing WAKIX franchise, the financial flexibility to invest in innovation, conviction to pursue strategic business development opportunities, and a pipeline led by BP-205 that has the potential to generate significant long-term value.”

Jeffrey Dayno, MD, President and Chief Executive Officer

“I am proud of the talented team and passionate organization we have built, which position Harmony for continued success in delivering innovative treatments to patients and sustained value for our shareholders.”

Jeffrey Dayno, MD, President and Chief Executive Officer
8:01 AM ET 8-K
Financial Results Burford Capital Ltd BUR

Burford Capital Financial Results

Burford Capital reported its financial results for the third quarter and first nine months of 2026, highlighting total revenues of $135 million. The company achieved $100 million in de-leveraging and ended the period with over $500 million in cash on hand.

Term
Q3 2026

“Burford had its strongest quarter this year, with robust portfolio activity and good cash generation. Total revenues of $135 million would have been well over $200 million if not for the non-cash increase in market discount rates. We also achieved $100 million of de-leveraging and retired our nearest-term debt maturity. We closed the quarter with more than a half-billion dollars of cash on hand.”

Christopher Bogart, Burford Capital’s Chief Executive Officer
8:01 AM ET 8-K
Financial Results Atlanta Braves Holdings, Inc. BATRA

Atlanta Braves Holdings Financial Results

Atlanta Braves Holdings reported third quarter 2026 financial results, with total revenue increasing 4% to $325 million driven by higher baseball event revenue and mixed-use development rental income. Operating income declined significantly to $9 million from $39 million in the prior year period, primarily due to increased player salaries. The company highlighted a 14% increase in average regular season home game attendance and the successful first season of its direct-to-consumer platform, BravesVision.

Term
3 months
7:55 AM ET 8-K
Financial Results Neuronetics, Inc. STIM

Neuronetics Financial Results

Neuronetics reported Q3 2026 total revenue of $42.0 million, a 12.5% increase year-over-year, driven primarily by 20.1% growth in its Greenbrook clinic segment. The company achieved a significant turnaround in profitability, reporting positive Adjusted EBITDA of $1.9 million and income from operations of $0.5 million compared to losses in the prior year period.

Term
Q3 2026

“This quarter showed our strategy taking hold across our business. We delivered a record third quarter within Greenbrook as well as NeuroStar system sales. This reflects both our revenue cycle management advances as well as the positive reception of our expanded NeuroStar go-to-market options. We also continued to demonstrate our prioritization on profitability and cashflow generation.”

Dan Reuvers, President and Chief Executive Officer of Neuronetics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.